Speaker(s): 

Cameron Hayes, MS, CGC- Genetic Counselor I, Geisinger, has nothing to disclose

Hannah Krammes, MS, CGC- Genetic Counselor I, Geisinger, has nothing to disclose

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

•Understand the benefits and limitations of MyCode/ Population Health Screening Participation

•Distinguish differences between clinical genetic testing and MyCode genomic screening

•Recognize potential areas for clinical genetic testing/counseling through case examples

•

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Juliann Savatt, MS, LCGC, Melissa Kelly, MS, LCGC, Marc Williams, MD, and Cara McCormick, MPH have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None